Cardiovascular disease (CVD) influences phenotypic variation in Parkinson’s disease (PD), and is usually an indication for statin therapy. It is less clear whether cardiovascular risk factors influence PD phenotype, and if statins are prescribed appropriately.
To quantify vascular risk and statin use in recent onset PD, and examine the relationship between vascular risk, PD severity and phenotype.
Cardiovascular risk w...Expand abstract
- Publication status:
- Peer review status:
- Peer reviewed
- Publisher's version
- BMJ Publishing Group Publisher's website
- Journal of Neurology, Neurosurgery, and Psychiatry Journal website
- Publication date:
- Acceptance date:
1468-330X and 0022-3050
- Pubs id:
- Local pid:
- Copyright holder:
- Hu et al
- Copyright date:
- This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/
Statins are underused in recent-onset Parkinson's disease with increased vascular risk: findings from the UK Tracking Parkinson's and Oxford Parkinson's Disease Centre (OPDC) discovery cohorts.
If you are the owner of this record, you can report an update to it here: Report update to this record